ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,457Medicare Part D Prescriptions Filled, Including Refills

Rank: 103 out of 2888

$921K Total Retail Price of All Prescriptions

Rank: 254 out of 2888

739 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

20% of this provider’s 739 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 15,018 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LEVOTHYROXINE SODIUM 1,130 943 1 1
LISINOPRIL 884 669 2 3
HYDROCODONE-ACETAMINOPHEN 795 441 S3 3 4
PRAVASTATIN SODIUM 695 533 4 12
OMEPRAZOLE 600 434 5 7
SIMVASTATIN 592 495 6 2
AMLODIPINE BESYLATE 561 465 7 5
METOPROLOL TARTRATE 524 440 8 10
FENOFIBRATE 504 390 9 65
LOSARTAN POTASSIUM 465 374 10 18
FUROSEMIDE 443 382 11 6
POTASSIUM CHLORIDE 420 323 12 14
METFORMIN HCL 365 285 13 8
GABAPENTIN 307 195 14 13
METOPROLOL SUCCINATE 284 251 15 11
DOXYCYCLINE HYCLATE 275 190 16 123
ZOLPIDEM TARTRATE 263 216 17 17
HYDROCHLOROTHIAZIDE 248 201 18 15
ATENOLOL 231 168 19 25
GLIMEPIRIDE 222 160 20 36
TRAMADOL HCL 212 146 21 16
LOSARTAN-HYDROCHLOROTHIAZIDE 204 147 22 46
ATORVASTATIN CALCIUM 180 157 23 9
WARFARIN SODIUM 177 166 24 22
MELOXICAM 171 139 25 31
PANTOPRAZOLE SODIUM 151 121 26 33
COMBIVENT 150 100 27 177
SERTRALINE HCL 146 91 28 27
DIOVAN 143 132 29 35
CLOPIDOGREL 139 109 30 30
GLIPIZIDE 138 111 31 50
NEXIUM 136 90 32 19
SPIRIVA 130 112 33 79
LISINOPRIL-HYDROCHLOROTHIAZIDE 128 119 34 28
CLONIDINE HCL 122 99 35 39
BENAZEPRIL HCL 118 79 36 77
CARVEDILOL 118 105 36 21
ENALAPRIL MALEATE 113 103 38 49
ZETIA 111 79 39 81
CITALOPRAM HBR 110 91 40 24
CIPROFLOXACIN HCL 110 89 40 47
CYCLOBENZAPRINE HCL 107 80 R 42 68
GEMFIBROZIL 103 97 43 98
DONEPEZIL HCL 101 90 44 26
LEVOFLOXACIN 100 75 45 57
ALPRAZOLAM 99 81 46 214
JANUVIA 97 85 47 48
DILTIAZEM 24HR ER 96 79 48 264
ALLOPURINOL 95 69 49 37
DIOVAN HCT 94 82 50 61
PLAVIX 92 74 51 40
DILTIAZEM ER 91 70 52 182
ALENDRONATE SODIUM 90 81 53 23
LANTUS 86 70 54 45
TAMSULOSIN HCL 83 64 55 29
LOVASTATIN 82 63 56 41
DILTIAZEM HCL 81 61 57 236
HUMULIN 70-30 81 55 57 230
ROPINIROLE HCL 80 58 59 115
VENTOLIN HFA 80 34 59 173
DILTIAZEM 24HR CD 78 70 61 146
ISOSORBIDE MONONITRATE ER 77 59 62 51
GLYBURIDE 75 70 R 63 58
RANITIDINE HCL 72 69 64 56
ADVAIR DISKUS 72 48 64 60
NAMENDA 70 70 66 34
DIGOXIN 69 57 67 55
AZITHROMYCIN 67 51 68 38
ESCITALOPRAM OXALATE 67 38 68 62
PREDNISONE 65 45 70 42
ATELVIA 65 50 70 201
SPIRONOLACTONE 64 25 72 70
AMITRIPTYLINE HCL 61 36 R 73 74
CARISOPRODOL 59 26 R 74 82
GLYBURIDE-METFORMIN HCL 58 54 R 75 64
METRONIDAZOLE 57 52 76 256
FLUOXETINE HCL 57 37 76 83
PAROXETINE HCL 55 49 78 84
AMOX TR-POTASSIUM CLAVULANATE 55 47 78 112
AMIODARONE HCL 55 53 78 167
TRAZODONE HCL 54 40 81 43
SINGULAIR 54 41 81 85
KLOR-CON M20 52 42 83 90
CYMBALTA 51 29 84 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 3, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.